566 related articles for article (PubMed ID: 29465360)
21. Description of patients with IgG4-related disease from a Hungarian centre.
Szántó A; Nagy G; Molnár CS; Griger Z; Tarr T; Zeher M
Scand J Rheumatol; 2014; 43(4):334-7. PubMed ID: 25087687
[TBL] [Abstract][Full Text] [Related]
22. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
[TBL] [Abstract][Full Text] [Related]
23. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
[TBL] [Abstract][Full Text] [Related]
24. Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome.
Loureiro-Amigo J; Palacio-García C; Martínez-Gallo M; Martínez-Valle F; Ramentol-Sintas M; Soláns-Laqué R
Rheumatology (Oxford); 2021 Dec; 60(12):5647-5658. PubMed ID: 33620072
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performances of serum IgG4 concentration and IgG4/IgG ratio in IgG4-related disease.
Xia CS; Fan CH; Liu YY
Clin Rheumatol; 2017 Dec; 36(12):2769-2774. PubMed ID: 28540606
[TBL] [Abstract][Full Text] [Related]
26. Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.
Vasaitis L; Sundström C; Backlin C; Nordmark G; Baecklund E
Acta Oncol; 2016; 55(9-10):1139-1144. PubMed ID: 27196149
[TBL] [Abstract][Full Text] [Related]
27. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
Barcelos F; Martins C; Papoila A; Geraldes C; Cardigos J; Nunes G; Lopes T; Alves N; Vaz-Patto J; Branco J; Borrego LM
Rheumatol Int; 2018 Jun; 38(6):1063-1073. PubMed ID: 29623391
[TBL] [Abstract][Full Text] [Related]
28. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
[TBL] [Abstract][Full Text] [Related]
29. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
30. A Comparative Analysis of Serum IgG4 Levels in Patients With IgG4-Related Disease and Other Disorders.
Wang L; Chu X; Ma Y; Zhang M; Wang X; Jin L; Tan Z; Li X; Li X
Am J Med Sci; 2017 Sep; 354(3):252-256. PubMed ID: 28918831
[TBL] [Abstract][Full Text] [Related]
31. Primary Sjögren's syndrome with chronic tubulointerstitial nephritis and lymphadenopathy mimicking IgG4-related disease.
Kawano M; Suzuki Y; Yamada K; Mizushima I; Matsumura M; Nakajima K; Yamagishi M; Yamaguchi Y
Mod Rheumatol; 2015 Jul; 25(4):637-41. PubMed ID: 24252015
[TBL] [Abstract][Full Text] [Related]
32. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
[TBL] [Abstract][Full Text] [Related]
33. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
34. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
[TBL] [Abstract][Full Text] [Related]
35. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
[TBL] [Abstract][Full Text] [Related]
36. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sjögren's syndrome.
Qin Q; Wang H; Wang HZ; Huang YL; Li H; Zhang WW; Zhang JR; He LL; Xia R; Zhao DB; Deng AM
Mod Rheumatol; 2014 Sep; 24(5):793-7. PubMed ID: 24372293
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of IgG4-related disease. Comparison with Sjögren's syndrome.
Tsuboi H; Honda F; Takahashi H; Ono Y; Abe S; Kondo Y; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Jan; 30(1):7-16. PubMed ID: 31425659
[TBL] [Abstract][Full Text] [Related]
39. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
40. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
